Atlas Trials

EF5 in Assessing Tumor Response to Anticancer Therapy in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer

Clinical trial NCT00041028 · COMPLETED

Trial details

NCT number
NCT00041028
Sponsor
Duke University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lung Cancer
Start date
2002-05-01
Primary completion
2007-09-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.